|Tender Details : |
Object of the contract
Description: Contract notice: Pharmaceutical products
Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union, with participation by GPA countries
Award criteria: Lowest price
CPV code: 33600000,33600000,33600000
CPV Description: Pharmaceutical products.
Amgros is a partnership with the 5 regions as stakeholders. In order to provide stakeholders' hospital pharmacies with medicines and the resale of individual stakeholders to the Faroe Islands and Greenland, Amgros I / S wishes to enter into framework agreements for the drugs listed in Section II.2.4). The framework agreements are non-exclusive. Amgros I / S forwarders laThe medicines for the hospital pharmacies to Amgros I / S 'purchase price with an addendum. Framework agreements are entered without specification, and hospital pharmacies in the regions are not obliged to use Amgros' framework agreements.
NUTS Code: DK0
Main Site: Place of delivery is the address of Amgros at the address (hospital pharmacy or affiliated locations).
The tender number includes the following medicines:
Offer No: 1,
ATC Code: J06BA,
Generic Name: Immunoglobulins, Normal Human,
Dispensing Form: Infusion Bag,
Unit Value: 320mg,
Quantity in Units: 1,282.
The above drugs are offered independently of the drugs Under the remaining tendering numbers.
Each tender number is considered a separate sub-agreement. A supplier will then be able to choose to offer 1, more or allBid numbers and allocation are made separately for each tender number. Reference is made to the terms of reference, including the submission of tenders under the individual tender numbers.
Under the name> Quantity in units Guidance for the single European tendering document cleaning <process, safely the mat is relevant.
No information required. II.2.3) Note that an overview ofDelivery points are available on Amgros' Delivery and Procurement Portal, https://levportal.amgros.dk. The overview is updated on the basis of the changes.
In relation to item no. II.2.4) Note that Amgros has considered whether the tender group can be further subdivided. Amgros has realized that this is not the case in the light of considerations of economies of scale that will not be realizableE by a further breakdown as well as costs and patient safety considerations related to the following contract and drug handling. II.1.5) and Item. II.2.6) Note that the estimated value in item II.1.5) is the total estimated value of all tender numbers (lots) during the duration of the framework agreement, incl. Possibility of extension, cf. II.2.7). In section II.2.6)Is the estimated value for each tender number incl. Possibility of extension given, cf. II.2.7).
It is also noted that the estimated value is based on historical consumption and that the actual purchase may therefore differ materially, cf. II.2.4), Title II of the Terms and Conditions. 3.6 and the Framework Agreement Item. 2. Quotation of the tender documents must be made in the tender system, cf. tender documentsProvisions for the provision.
Admission to tender requires that the company be established as a user of Amgros' procurement system. There may be some processing days associated with user creation, and it is therefore inconvenient for any bidders to do so in good time. Reference is made to information relating to the procurement system, including the user guide. IV.2.4) Please note that some parts of the offer may also be in English. Reference is made to the terms of the tender terms. 4.1.
In relation to point VI.2) Note that electronic invoicing is required
Internet address (URL): http://www.amgros.dk
Directive: Classical Directive (2014/24/EU)